IBCC Episode 101 - Stress Hyperglycemia in the ICU
Oct 19, 2020
auto_awesome
Explore the overlooked topic of glycemic control in the ICU. Discuss the benefits, harms, and metabolic effects of stress-induced hyperglycemia. Learn about the relationship between autophagy, feeding in ICU, and glucose levels. Debate the optimal range for managing stress hyperglycemia. Discover the algorithm for insulin therapy and the need for auditing.
Stress hyperglycemia in the ICU can have potential benefits like providing glucose to poorly perfused tissues, but also potential harms such as impaired urine output and capillary leak.
Insulin therapy for stress hyperglycemia in the ICU should be approached cautiously due to potential risks and lack of high-quality evidence supporting tight glucose control.
Deep dives
Stress Hyperglycemia in the ICU: Potential Benefits and Harms
Stress hyperglycemia in the ICU occurs when glucose levels increase due to hormones such as cortisol and glucagon. This can have potential benefits, including providing glucose to poorly perfused tissues and reducing inflammation. However, there are also potential harms, such as impaired urine output as a marker for tissue perfusion, impaired function of the endothelial glycocalyx leading to capillary leak, and potential hypernatremia due to diuresis. Additionally, insulin therapy for stress hyperglycemia can have iatrogenic effects, including severe hypoglycemia and adverse drug reactions. Overall, there is no high-quality evidence to support the tight control of glucose levels in the ICU, and insulin therapy should be approached with caution due to its potential risks.
Chronic Hyperglycemia in Critically Ill Patients: Individualized Approach
For patients with chronic hyperglycemia, particularly those with longstanding diabetes and a hemoglobin A1C over 7, a more permissive glucose target of 180 to 250 mg per dl may be appropriate. Evidence suggests that their bodies may be ill-adapted to handle a normal glucose range and that dropping their glucose levels too rapidly can be harmful. For non-diabetic patients, a target glucose range of 100 to 220 mg per dl may be reasonable. It is important to emphasize that the approach to achieving these target levels should be slow and steady, and attention should be given to avoiding hypoglycemia.
Insulin Therapy in the ICU: Proceed with Caution
Insulin therapy for stress hyperglycemia in the ICU should be approached with caution due to the potential for harm. The current evidence, exemplified by the NICE-SUGAR trial, suggests that tight control of glucose levels is inferior to a more liberal control approach. However, there is still significant debate and uncertainty regarding the ideal glucose target range. It is crucial to individualize treatment based on factors such as the patient's medical history, presence of diabetes, and glycemic variability. Insulin therapy should be audited and closely monitored to avoid aggressive glucose lowering and the risk of hypoglycemia. Overall, the focus should be on avoiding harm and maintaining safe glucose levels rather than achieving rigid glucose targets.
In this episode we cover the often overlooked topic of glycemic control in the ICU. What blood sugar should we be targeting? Is that hyperglycaemia a stress response? Insulin resistance? Iatrogenic? All of the above. Come listen to our discussion, and Josh's attempt at clearing up a confused evidence base.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.